Large Cap
Pharmaceutical Preparations
Stocks Ranked by
Market Capitalization
| # | Name | Market cap | Price | Price change % | |
|---|---|---|---|---|---|
 1 Abbott ABT $196B | $196B | $112.64 | +0.37% | ||
 2 Pfizer PFE $162B | $162B | $28.58 | +0.85% | ||
 3 Vertex Pharmaceuticals VRTX $118B | $118B | $455.31 | +0.39% | ||
 4 Regeneron Pharmaceuticals REGN $112B | $112B | $1,012.82 | -0.17% | ||
 5 Bristol-Myers Squibb BMY $109B | $109B | $53.96 | -0.44% | ||
 6 Zoetis ZTS $86.1B | $86.1B | $190.03 | -0.5% | ||
 7 Alnylam Pharmaceuticals ALNY $34.4B | $34.4B | $267.99 | -0.57% | ||
 8 BeiGene BGNE $26B | $26B | $246.04 | +5.31% | ||
 9 Teva Pharmaceuticals TEVA $19.8B | $19.8B | $17.49 | +0.63% | ||
 10 United Therapeutics UTHR $15.8B | $15.8B | $355.93 | +1.67% | ||
 11 Tenet Healthcare THC $15.3B | $15.3B | $156.57 | -0.11% | ||
 12 Summit Therapeutics SMMT $14B | $14B | $19.09 | +2.58% | ||
 13 Viatris VTRS $13.8B | $13.8B | $11.59 | +1.4% | ||
 14 BioMarin Pharmaceuticals BMRN $13.2B | $13.2B | $69.51 | +1.98% | ||
 15 Royalty Pharma RPRX $12.4B | $12.4B | $27.75 | +0% | ||
 16 Insmed INSM $12.4B | $12.4B | $72.27 | +1.22% | ||
 17 Sarepta Therapeutics SRPT $11.5B | $11.5B | $120.40 | +1.38% | ||
 18 Catalent CTLT $11B | $11B | $60.59 | -0.2% |